drugset
drugset / Trial / NCT05553678

The Effect of MDZ on Movement During UIA Clipping

NCT05553678 ↗

Phase 4 Unknown 64 enrolled Seoul National University Hospital
RandomizedParallel-groupTriple-blindPrevention

Summary

This study is a randomized, controlled, double-blinded, and parallel design study. A total 64 patients will be randomized to receive midazolam or normal saline during unruptured intracranial aneurysm clipping surgery.

Timeline

Start
2022-09-29
Primary completion
2023-09-30
Completion
2023-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Midazolam Small molecule 0.03 mg/kg —

Indications

No indication recorded.